Parallax Volatility Advisers, L.P. Astrazeneca PLC Put Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Put Options

20 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $782,034 - $893,724	10,200 Added 147.83%	17,100 $1.33 Million
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $14.9 Million - $18 Million	-222,300 Reduced 96.99%	6,900 $538,000
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $10.8 Million - $12.3 Million	177,100 Added 339.92%	229,200 $15.5 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $482,742 - $540,384	-7,800 Reduced 13.02%	52,100 $3.51 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $17.4 Million - $19.3 Million	-268,700 Reduced 81.77%	59,900 $4.06 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $22.1 Million - $23.9 Million	315,500 Added 2408.4%	328,600 $23.5 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $3.62 Million - $4.11 Million	-57,400 Reduced 81.42%	13,100 $909,000
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $4.21 Million - $5.47 Million	-77,600 Reduced 52.4%	70,500 $4.78 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $3.42 Million - $8.76 Million	64,500 Added 77.15%	148,100 $8.12 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $3.29 Million - $3.95 Million	55,500 Added 197.51%	83,600 $5.52 Million
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $295,316 - $355,736	-5,300 Reduced 15.87%	28,100 $1.86 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $2.07 Million - $2.45 Million	-38,400 Reduced 53.48%	33,400 $1.95 Million
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $3.39 Million - $3.71 Million	61,064 Added 568.78%	71,800 $4.31 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $75,728 - $94,121	-1,564 Reduced 12.72%	10,736 $643,000
Q4 2020 Feb 16, 2021	SELL	$48.52 - $58.02 $3.85 Million - $4.6 Million	-79,300 Reduced 86.57%	12,300 $615,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $4.31 Million - $4.96 Million	81,200 Added 780.77%	91,600 $5.02 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $439,620 - $564,162	10,200 Added 5100.0%	10,400 $549,000
Q4 2018 Feb 14, 2019	SELL	$36.86 - $41.49 $29,488 - $33,192	-800 Reduced 80.0%	200 $8,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $20,856 - $23,832	600 Added 150.0%	1,000 $40,000
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $13,188 - $14,652	400 New	400 $14,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.07 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.41 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.38 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.24 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account